Primary nephrotic syndorme in children;Síndrome nefrótico idiopático en el niño

Nefrologia

Volumn 27, Issue SUPPL.2, 2007, Pages 33-44

  Zamora, I ^a   Pena A ^a   Mendizabal S ^a   Bedoya, R ^b   Vilalta, R ^a   Torra, R ^c  

^a Nefrología Infantil La Fe ^*  (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83055198736     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. International Study of kidney disease in children: the primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98: 561-564, 1981.
2. Adu A: The nephrotic syndrome: does renal biopsy affect management? Nephrol Dial Transplant 11: 12-14, 1996.
3. Kassier JP: Is renal biopsy necessary for optimal management of the idiopathic nephrotic syndrome? Kidney Int 24: 561- 565, 1983.
4. Bargman JM: Management of minimal lesion glomerulonephritis: Evidence-based recommendations. Kidney Int (Supl.) 70: S3-16, 1999.
5. Ehrich JH, Brodehl J: Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152 (4): 357-61, 1993.
6. Hodson EM, Knight JF, Willis NS y cols.: Corticosteroid therapy for nephrotic syndrome in children (Cochrane Review). En: The Cochrane Library, Issue2, 2002. Oxford: Update Software.
7. Hodson, EM, Craig JC, Willis NS: Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol (11): 1523-30, 2005.
8. Tarshish P, Tobin JN, Bernstein J, Edelmann CM, Jr.: Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8: 769-776, 1997.
9. Latta K, Von Schnakenburg C, Ehrich JH: A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16 (3): 271-82, 2001.
10. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G: Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet 2: 423-427, 1974.
11. Report of the International Study of Kidney Disease in Children: Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 2 (7878): 423-7, 1974.
12. Durkan AM, Hodson EM, Willis NS y cols.: Immunosuppresive agents in childhood nephrotic syndrome: a meta-analysis of randomised controlled trials. Kidney Int 59: 1919, 2001.
13. Chandra M, Susin M, Abitbol C: Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil. Pediatr Nephrol 14: 224-226, 2000.
14. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simón J: Mycophenolate mofetil in steroid/cyclosporine-dependent/ resistant nephrotic syndrome. Pediatr Nephrol 20 (7): 914-9, 2005.
15. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB: Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18: 833-837, 2003.
16. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M: Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience. Nephrol Dial Transplant 20: 2433-2438, 2005.
17. García C, Michelon T, Barros V, Mota D, Uhlmann A, Randon R, Ramalho H, Abbud FM: Cyclosporine in the treatment of steroid-dependent and steroid-resistant idiopathic nephrotic syndrome in children. Transplant Proc 30: 4156-4157, 1998.
18. Niaudet P: Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 125: 981- 986, 1994.
19. Zacchello G, Confalonieri R, Altieri P y cols.: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomised controlled trial. Nephrol Dial Transplant 8 (12): 1326-32, 1993.
20. Hymes LC: Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome. Pediatr Nephrol 9: 137-139, 1995.
21. Identification of constitutional WT1 mutations, in patients with isolated Diffuse Mesangial Sclerosis, and analyse of genotype/ phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62: 824-33, 1998.
22. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM: Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 4: 303-307, 1990.
23. Mori K, Honda M, Ikeda M: Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19: 1232-1236, 2004.
24. Rose GM, Cole BR, Robson AM: The treatment of severe glomerulopathies in children using high dose intravenous methylprednisolone pulses. Am J Kidney Dis 1: 148-156, 1981.
25. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr.: Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10 (5): 590-3, 1996.
26. Simón J, Zamora I: Nefropatías Glomerulares primarias en Nefrología Clínica. L. Hernando. Editorial Panamericana 289- 295, 2003.
27. McCauley J, Shapiro R, Ellis D, Igdal H, Tzakis A, Starzl TE: Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 8: 1286-1290, 1993.
28. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A: Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13: 388-393, 2002.
29. Caridi G, Perfumo F, Ghiggeri G: NPHS1-NPHS2 mutations in nephritic syndrome. Clinical spectrum and fine mechanisms. Pediatric Research 57: 54R, 2005.
30. Vats A, Nayak A, Ellis D Randhawa PS, Finegold DN, Levinson KL, Ferrell RE: Familial nephrotic syndrome: clinical spectrum and linkage to chromosome 19q13. Kidney Int 57 (3): 875-81, 2000.
31. Lenkkeri U, Mannikko M, Holmberg C y cols.: Structure of the gene for congenital nephritic syndrome of Finnish type. (NPHS1) ans characterization of mutations. Am J Hum Genet 64: 51-61, 1999.
32. Koziel AB y cols.: Evidence for the genetic herterogeneity of nephropathic phenotypes associated with Denys-Drash and Frasier syndromes. Am J Hum Genet 64: 1778-91, 1999.
33. Kovacevic L y cols.: Management of congenital nephritic syndrome. Pediatr Nephrol 18: 426-430, 2003.
34. Kim M, Stablein D y cols.: Renal transplantation in children with congenital nephrotic syndrome: a Report of the North American Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transpl 2: 305-308, 1998.
35. Srivastava T, Garola R, Kestila M y cols.: Recurrente of proteinuria following renal transplantation in congenital nephrotic síndrome of the Finnish type. Pediatr Nephrol 21: 711- 718, 2006.
36. Seikaly MG: Recurrence of primary disease in children after renal transplantation: an evidence-based update. Pediatr Transplantation 8: 113-119, 2004.
37. Flooge J: Recurrent glomerulonephritis following renal transplantation? An updtate. Nephrol Dial Transplant 18: 1260- 1265, 2003.
38. Dall'Amico R, Ghiggeri GM, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F: Prediction and treatment of Recurrent Segmental Glomeruloclerosis After Renal Transplantation in Children. American Journal of Kidney Diseases, 34, No 6. pp. 1048-1055, 1999.